Baricitinib: A chance to treat COVID-19?

J Med Virol. 2020 Nov;92(11):2343-2344. doi: 10.1002/jmv.26033. Epub 2020 Jun 2.

Authors

Sergio Lo Caputo¹, Gaetano Corso², Mario Clerici³, Teresa Antonia Santantonio¹

Affiliations

¹ Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
² Clinical Biochemistry and Clinical Molecular Biology, Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
³ Department of Pathophysiology and Transplantation, Don C Gnocchi Foundation IRCCS, University of Milano, Milano, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Azetidines / therapeutic use*
COVID-19 / diagnostic imaging
COVID-19 Drug Treatment*
Female
Humans
Italy
Purines / therapeutic use*
Pyrazoles / therapeutic use*
Sulfonamides / therapeutic use*
Treatment Outcome

Substances

Azetidines
Purines
Pyrazoles
Sulfonamides
baricitinib